Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal effects

C A Chiriboga1

  • 1Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York.

Neurologic Clinics
|August 1, 1993
PubMed
Summary

Prenatal drug exposure can lead to fetal growth restriction, with alcohol showing strong links to fetal alcohol syndrome (FAS). Other drug effects on development are less clear, but opiate-exposed infants may be more vulnerable in poor environments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aromatic L-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis.

Neurology·2004
Same author

Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review.

Pediatric neurology·2000
Same author

Dose-response effect of cocaine on newborn head circumference.

Pediatrics·2000
Same author

Dose-response effect of fetal cocaine exposure on newborn neurologic function.

Pediatrics·1999
Same author

Neurological correlates of fetal cocaine exposure.

Annals of the New York Academy of Sciences·1998
Same author

Massive intracranial arachnoid cyst in a developmentally normal infant: case report and literature review.

Pediatric neurology·1997

Area of Science:

  • Perinatology
  • Developmental Psychology
  • Pharmacology

Background:

  • Fetal drug exposure is a significant concern with documented adverse effects.
  • Alcohol's teratogenic effects, including fetal alcohol syndrome (FAS), are well-established.
  • Evidence for other prenatal drug exposures (marijuana, cigarettes, cocaine, opiates) on neurodevelopment is less conclusive.

Purpose of the Study:

  • To review the established and potential adverse effects of prenatal drug exposure on fetal development and neurobehavior.
  • To differentiate the strength of evidence for various substances, particularly alcohol.

Main Methods:

  • Literature review and synthesis of existing research on prenatal drug exposure and outcomes.
  • Analysis of evidence for teratogenic, cognitive, behavioral, and growth effects.

Main Results:

  • Alcohol exposure is strongly linked to fetal alcohol syndrome (FAS), intrauterine growth restriction (IUGR), birth defects, and mental retardation.
  • Evidence for cognitive or behavioral deficits from prenatal marijuana, cigarette, cocaine, or opiate exposure is not well-established.
  • Intrauterine growth restriction (IUGR), especially of the brain, is the most consistently observed effect across various drug exposures and may mediate cognitive impacts.
  • Neonatal neurobehavioral abnormalities in exposed infants did not appear to impact subsequent development.
  • Opiate-exposed infants, particularly those with withdrawal, are more vulnerable to adverse outcomes in impoverished environments.

Conclusions:

  • Alcohol poses a significant, well-documented risk to fetal development.
  • The long-term cognitive and behavioral impacts of prenatal exposure to marijuana, cigarettes, cocaine, and opiates require further investigation.
  • Impaired fetal growth is a key outcome of prenatal drug exposure, potentially influencing cognitive development.
  • Environmental factors significantly moderate the developmental trajectory of opiate-exposed infants.

Related Experiment Videos